Details for New Drug Application (NDA): 018027
✉ Email this page to a colleague
The generic ingredient in LITHOBID is lithium carbonate. There are fifteen drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the lithium carbonate profile page.
Summary for 018027
Tradename: | LITHOBID |
Applicant: | Ani Pharms |
Ingredient: | lithium carbonate |
Patents: | 0 |
Suppliers and Packaging for NDA: 018027
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LITHOBID | lithium carbonate | TABLET, EXTENDED RELEASE;ORAL | 018027 | NDA | ANI Pharmaceuticals, Inc. | 62559-280 | 62559-280-01 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (62559-280-01) |
LITHOBID | lithium carbonate | TABLET, EXTENDED RELEASE;ORAL | 018027 | NDA AUTHORIZED GENERIC | Proficient Rx LP | 71205-238 | 71205-238-30 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71205-238-30) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 300MG | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 018027
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Ani Pharms | LITHOBID | lithium carbonate | TABLET, EXTENDED RELEASE;ORAL | 018027-001 | Approved Prior to Jan 1, 1982 | ⤷ Subscribe | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription